PATENT CLAIM ANALYSIS

Application Number: 15877750
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "439000"]

Abstract:
The present invention discloses compositions which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. Furthermore, the invention provides diets, nutraceuticals and nutrition oral rehydration therapy, means and methods useful in treating and inducing of remission of inflammation in IBD patients.

Claim (Index 4):
The composition for either treating IBD or inducing of remission of IBD patients of  claim 1 , wherein the compositions are (i) about 85% steviol glycoside extract ranging from about 0.01% to about 0.03% w/w, (ii) about 0.20% w/w citric acid monohydrate; (iii) monosodium glutamate ranging from about 0.05% to about 0.80% w/w; and (iv) about 0.35% w/w glycine.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.25641
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15527724', '14360863', '12685979', '14044546', '13523683']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7352984225335462
- 35 USC 102 Novelty (BERT): 0.5267075153818815
- Combined Prediction Score: 0.7144393318183797
- Mean Citation Score: 202.86906
- Max Citation Score: 327.8126200000001
- Similarity Product: 209.3864086650098

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test